Literature DB >> 157095

Autoantibodies and the spectrum of Sjögren's syndrome.

M Martinez-Lavin, J H Vaughan, E M Tan.   

Abstract

In studies reported recently, the sera of patients with Sjögren's syndrome were found to contain precipitating antibodies to nuclear antigens that can be identified by immunodiffusion analysis. These precipitating autoantibodies have been termed SS-A and SS-B antibodies. We show that identification of these autoantibodies helped in establishing the diagnosis of Sjögren's syndrome in 12 of 30 patients in whom the diagnosis had not been considered at the time of the physician's initial examination. The reasons for this were related to lack of spontaneous complaints of keratoconjunctivitis sicca and xerostomia and prominence of symptoms associated with arthritis, myalgia, pulmonary fibrosis, and cardiac disease. This study re-emphasizes the importance of multisystem disease in Sjögren's syndrome and shows that specific serologic assays for autoantibodies aided in diagnosis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 157095     DOI: 10.7326/0003-4819-91-2-185

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  22 in total

1.  The specificity of antiglobulin autoantibodies in patients with primary Sjögren's syndrome.

Authors:  T Wada; I Ezaki; M Shingu; S Nonaka; E Ohtsuka; M Yasuda; M Nobunaga
Journal:  Clin Rheumatol       Date:  1990-12       Impact factor: 2.980

2.  Clinical analysis of primary Sjögren's syndrome complicating anemia.

Authors:  Jing-Guo Zhou; Yu-Feng Qing; Li Jiang; Qi-Bin Yang; Wen-Feng Luo
Journal:  Clin Rheumatol       Date:  2010-02-20       Impact factor: 2.980

3.  Release of calreticulin from neutrophils may alter C1q-mediated immune functions.

Authors:  U Kishore; R D Sontheimer; K N Sastry; K S Zaner; E G Zappi; G R Hughes; M A Khamashta; P Strong; K B Reid; P Eggleton
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

Review 4.  Clinical relevance of autoantibodies in systemic rheumatic diseases.

Authors:  M J Fritzler
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

5.  Unusual presentation of Sjögren's syndrome.

Authors:  Aicha Bouraoui; Syed Farhan Bari; Julian Nash; Kenneth Dawson
Journal:  BMJ Case Rep       Date:  2014-11-20

6.  Molecular cloning, expression, and chromosome 19 localization of a human Ro/SS-A autoantigen.

Authors:  D P McCauliffe; F A Lux; T S Lieu; I Sanz; J Hanke; M M Newkirk; L L Bachinski; Y Itoh; M J Siciliano; M Reichlin
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

7.  Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE).

Authors:  R H van den Berg; C E Siegert; M C Faber-Krol; T W Huizinga; L A van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

8.  Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus.

Authors:  M L Boey; C L Peebles; G Tsay; P H Feng; E M Tan
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

9.  Systemic lupus erythematosus presenting as polymyalgia rheumatica in the elderly.

Authors:  C W Hutton; P J Maddison
Journal:  Ann Rheum Dis       Date:  1986-08       Impact factor: 19.103

10.  Sjögren's syndrome in a child.

Authors:  C Vermylen; A Meurant; H Noël; D Claus; G Cornu
Journal:  Eur J Pediatr       Date:  1985-09       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.